100861-38-9

Basic information

• Product Name: 3-METHOXY-4-METHYLPHENYLACETIC ACID
• Synonyms: Benzeneacetic acid, 3-methoxy-4-methyl-
• CAS NO: 100861-38-9
• Molecular Formula: C₁₀H₁₂O₃
• Molecular Weight: 180.2
• Mol File: 100861-38-9.mol
• Article Data: 5

Chemical Properties

• Melting Point: 82 °C
• Boiling Point: 313.6°Cat760mmHg
• Flash Point: 123.5°C
• Appearance: /
• Density: 1.146g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.534
• Storage Temp.: 2-8°C
• PKA: 4.28±0.10(Predicted)
• CAS DataBase Reference: 3-METHOXY-4-METHYLPHENYLACETIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-METHOXY-4-METHYLPHENYLACETIC ACID(100861-38-9)
• EPA Substance Registry System: 3-METHOXY-4-METHYLPHENYLACETIC ACID(100861-38-9)

Safety Data

• Hazardous Substances Data: 100861-38-9(Hazardous Substances Data)

Usage

Uses

3-Methoxy-4-methylphenylacetic Acid is synthetically prepared by benzylic metalation of substituted toluenes using a mixed metal (Li/K) amide base to facilitate an anion migration from the kinetic to the benzylic metalation site.

InChI:InChI=1/C10H12O3/c1-7-3-4-8(6-10(11)12)5-9(7)13-2/h3-5H,6H2,1-2H3,(H,11,12)

Upstream product

• 124-38-9 carbon dioxide 
• 1706-11-2 2,5-Dimethyl-anisol 
• 3556-81-8 1-(3-methoxy-4-methylphenyl)ethan-1-one 
• 64829-31-8 2-(3-methoxy-4-methylphenyl)acetonitrile 
• 92501-14-9 4-[(3-methoxy-4-methyl-phenyl)-thioacetyl]-morpholine 

Downstream Products

• 1200397-46-1 ethyl 2-(3-(2,6-dimethylbenzyloxy)-4-methylphenyl)acetate 
• 1200397-14-3 2-(3-(2,6-dimethylbenzyloxy)-4-methylphenyl)acetic acid 
• 1292688-19-7 ethyl 2-(3-(3-methoxy-2,6-dimethylbenzyloxy)-4-methylphenyl)acetate 
• 1292687-96-7 2-(3-(3-methoxy-2,6-dimethylbenzyloxy)-4-methylphenyl)acetic acid 
• 1292687-94-5 3-((5-(carboxymethyl)-2-methylphenoxy)methyl)-2,4-dimethylphenyl sulfate 
• 1292688-13-1 ethyl 2-(3-(3-(tert-butyldimethylsilyloxy)-2,6-dimethylbenzyloxy)-4-methylphenyl)acetate 
• 1292688-15-3 ethyl 2-(3-(3-hydroxy-2,6-dimethylbenzyloxy)-4-methylphenyl)acetate 
• 1292687-92-3 2-(3-(3-hydroxy-2,6-dimethylbenzyloxy)-4-methylphenyl)acetic acid 
• 765302-48-5 ethyl 2-(3-hydroxy-4-methylphenyl)acetate 
• 765302-47-4 ethyl 2-(3-methoxy-4-methylphenyl)acetate 
• 75097-32-4 2-bromo-5-methoxy-4-methylphenylacetic acid 
• 1036388-66-5 2-(3-methoxy-4-methylphenyl)ethan-1-ol 
• 18215-18-4 N-<3-Methoxy-4-methyl-phenaethyl>-<3.4-dimethyl-phenylacetamid> 
• 18149-16-1 1′-(3-methoxy-4-methylphenyl)ethyl-2′-amine 

Relevant articles and documents

Nucleoside analogs useful as PRMT5 inhibitors

The invention relates to the technical field of biological medicines, and particularly discloses a nucleoside analogue used as a PRMT5 inhibitor. According to the nucleoside analogue as shown in the formula (I) or the pharmaceutically acceptable salt of the nucleoside analogue, the nucleoside analogue or the pharmaceutically acceptable salt of the nucleoside analogue shows relatively high inhibition on the activity of PRMT5 and can be used for preventing and/or treating PRMT5-mediated diseases, and the PRMT5-mediated diseases comprise cell abnormal proliferative diseases.

3-SUBSTITUTED COMPOUNDS FOR REDUCING URIC ACID

Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula 1. The uric acid-lowering effects of the compounds of this invention are used to treat or prevent a variety of conditions including g

ARYL AND HETEROARYL TETRAHYDROBENZAZEPINE DERIVATIVES AND THEIR USE FOR TREATING GLAUCOMA

Aryl tetrahydrobenzazepine derivatives with minimal 5-HT2B activity relative to 5-HT2A and 5-HT2C activity that are useful for treating glaucoma are disclosed.